BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23018629)

  • 1. Fibroblast autophagy in fibrotic disorders.
    Del Principe D; Lista P; Malorni W; Giammarioli AM
    J Pathol; 2013 Jan; 229(2):208-20. PubMed ID: 23018629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective autophagy in fibroblasts may contribute to fibrogenesis in autoimmune processes.
    Del Principe D; Vona R; Giordani L; Straface E; Giammarioli AM
    Curr Pharm Des; 2011 Dec; 17(35):3878-87. PubMed ID: 21933148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis.
    Laurent GJ; Chambers RC; Hill MR; McAnulty RJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):647-51. PubMed ID: 17635112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Into the matrix: targeting fibroblasts in pulmonary fibrosis.
    Sivakumar P; Ntolios P; Jenkins G; Laurent G
    Curr Opin Pulm Med; 2012 Sep; 18(5):462-9. PubMed ID: 22847104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis and immune dysregulation in systemic sclerosis.
    Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
    Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular and cellular mechanisms of organ fibrosis].
    Oka T; Komuro I
    Nihon Rinsho; 2012 Sep; 70(9):1510-6. PubMed ID: 23012796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
    Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
    J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H; ZHENG M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast heterogeneity in physiological conditions and fibrotic disease.
    Jelaska A; Strehlow D; Korn JH
    Springer Semin Immunopathol; 1999; 21(4):385-95. PubMed ID: 10945032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
    Chizzolini C
    Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
    Yamamoto T; Nishioka K
    Exp Dermatol; 2005 Feb; 14(2):81-95. PubMed ID: 15679577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts.
    Schievenbusch S; Strack I; Scheffler M; Wennhold K; Maurer J; Nischt R; Dienes HP; Odenthal M
    Biochem Biophys Res Commun; 2009 Jul; 385(1):55-61. PubMed ID: 19426716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroproliferative disorders and their mechanobiology.
    Huang C; Ogawa R
    Connect Tissue Res; 2012; 53(3):187-96. PubMed ID: 22329637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrotic disorders in the eye: targets of gene therapy.
    Saika S; Yamanaka O; Sumioka T; Miyamoto T; Miyazaki K; Okada Y; Kitano A; Shirai K; Tanaka S; Ikeda K
    Prog Retin Eye Res; 2008 Mar; 27(2):177-96. PubMed ID: 18243038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibroblasts: from development to heart failure.
    Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM
    J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties and Immune Function of Cardiac Fibroblasts.
    Furtado MB; Hasham M
    Adv Exp Med Biol; 2017; 1003():35-70. PubMed ID: 28667553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of fibrosis by the immune system.
    Lupher ML; Gallatin WM
    Adv Immunol; 2006; 89():245-88. PubMed ID: 16682276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.